In the 2022-2023 influenza season, over half of the U.S. adult population does not get their flu vaccines. Many people may have forgotten how dangerous the flu can be. The truth is, the flu can lead to serious complications, like pneumonia, heart attack, and stroke. Older adults and people with certain chronic health conditions are at higher risk. Black Americans, American Indians, Alaska Natives and Hispanic Americans had higher rates of severe flu outcomes, including hospitalization and ICU admission, from 2009-2019 compared to White people. Since 2010, vaccination coverage has been consistently lower for Black, Hispanic, and AI/AN adults.
Each community may experience flu activity at different times, but last season, flu cases peaked in December. As long as flu viruses are circulating, vaccination should continue, even in December or later. Everyone eligible person should do their part and get vaccinated with Sanofi higher-dose flu vaccines – Sanofi’s Fluzone High-Dose Quadrivalent (Influenza Vaccine) and Flublok Quadrivalent (Influenza Vaccine).
To learn more, visit SanofiFluShots.com.
IMPORTANT SAFETY INFORMATION
Flublok Quadrivalent and Fluzone High-Dose Quadrivalent should not be given to anyone who has had a severe allergic reaction (anaphylaxis) to any component of the vaccine (including egg protein for Fluzone High-Dose Quadrivalent). In addition, Fluzone High-Dose Quadrivalent should not be given to anyone who has had a severe allergic reaction after previous dose of any influenza vaccine.
Tell your health care provider if you have ever had Guillain-Barré syndrome (severe muscle weakness) after a previous influenza vaccination.
If Flublok Quadrivalent and Fluzone High-Dose Quadrivalent are given to people with a compromised immune system, including those receiving therapies that suppress the immune system, the immune response may be lower than expected.
Vaccination with Flublok Quadrivalent and Fluzone High-Dose Quadrivalent may not protect all people who receive the vaccine.
For Flublok Quadrivalent, in adults 18 through 49 years of age, the most common side effects were tenderness, and/or pain where you got the shot; headache, tiredness, muscle aches, and joint pain. In adults 50 years of age and older the most common side effects were tenderness, and/or pain where you got the shot; headache, and tiredness.
For Fluzone High-Dose Quadrivalent, in adults 65 years of age and older, the most common side effects were pain, redness, and/or swelling where you got the shot; muscle aches, headache, and general discomfort.
For Flublok Quadrivalent and Fluzone High-Dose Quadrivalent, other side effects may occur.
For more information, talk to your health care professional and refer to the full Prescribing Information for Flublok Quadrivalent or Fluzone High-Dose Quadrivalent. Also, please see complete Patient Information for Fluzone High-Dose Quadrivalent.
MAT-US-2310972-v1.0-12/2023
